A2 BIOTHERAPEUTICS

A2 Biotherapeutics, Inc.

Application Filed: 2023-02-15
Trademark Application Details
Trademark Logo A2 BIOTHERAPEUTICS

Mark For: A2 BIOTHERAPEUTICS™ trademark registration is intended to cover the categories of therapeutics; biotherapeutics; medicines; pharmaceuticals; pharmaceutical products for the treatment and prevention of cancer and inflammatory diseases; therapeutic targets for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cell therapies for the treatment of cancer, inflammation, and inflammatory diseases; engineered cell therapies; engineered cell therapy platforms; cell platforms for the treatment and prevention of cancer, inflammation and inflammatory diseases; technology platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer, inflammation, and inflammatory diseases; platform for autologous and allogeneic cell manufacturing; therapeutics and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer, inflammation and inflammatory diseases; gene therapy products, namely, genetically engineered tissues for transplant purposes.

Status

2023-02-18 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number97796895
Mark Literal ElementsA2 BIOTHERAPEUTICS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationNEW APPLICATION PROCESSING 2023-02-18
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJoi A. White
Attorney Docket NumberT-4336/2 US

Timeline

2023-02-15Application Filed
2023-02-18Location: NEW APPLICATION PROCESSING
2023-02-18Status: Live/Pending
2023-02-18Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2023-02-18Transaction Date

Trademark Parties (Applicants & Owners)

Party: A2 Biotherapeutics, Inc.
Address30301 Agoura Road, Suite 210 Agoura Hills, CALIFORNIA UNITED STATES 91301
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Application2023-02-15
Drawing2023-02-15

Attorney of Record

JOI A. WHITE
CARR & FERRELL LLP
411 BOREL AVENUE, SUITE 603
SAN MATEO, CA 94402

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
Type CodeType
GS0051Therapeutics; biotherapeutics; medicines; pharmaceuticals; pharmaceutical products for the treatment and prevention of cancer and inflammatory diseases; therapeutic targets for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cell therapies for the treatment of cancer, inflammation, and inflammatory diseases; engineered cell therapies; engineered cell therapy platforms; cell platforms for the treatment and prevention of cancer, inflammation and inflammatory diseases; technology platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer, inflammation, and inflammatory diseases; platform for autologous and allogeneic cell manufacturing; therapeutics and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer, inflammation and inflammatory diseases; gene therapy products, namely, genetically engineered tissues for transplant purposes

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED2023-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed